Clinical trials
Retinitis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2011 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Active, not recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 14 |
| Hoffmann-La Roche | 6 |
| Astra USA | 4 |
| Roche Global Development | 3 |
| Gilead Sciences | 2 |
| Nanoscope Therapeutics Inc. | 2 |
| National Eye Institute (NEI) | 2 |
| American National Red Cross | 1 |
| Chiron Corporation | 1 |
| Daniel Benjamin | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinitis | 41 |
| Acquired Immunodeficiency Syndrome | 35 |
| Cytomegalovirus Retinitis | 34 |
| HIV Infections | 34 |
| Cytomegalovirus Infections | 30 |
| Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 24 |
| AIDS-Related Opportunistic Infections | 15 |
| Retinitis Pigmentosa | 4 |
| Eye Diseases | 3 |
| Eye Diseases, Hereditary | 3 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.